Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Conference News EuroPCR 2025

Meta-analysis Quashes Hopes for Routine Embolic Protection in TAVI

Michael O'Riordan

May 21, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2025

Caitlin E. Cox

April 30, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2025

Caitlin E. Cox

April 01, 2025

News Conference News ACC 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Michael O'Riordan

March 30, 2025

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

News Conference News TCT 2024

Top Structural Heart News of 2022

L.A. McKeown

January 06, 2023

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

Shelley Wood

December 30, 2022

News Conference News TCT 2022

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Caitlin E. Cox

September 19, 2022

Presentation TCT 2022

None Use: The Data Are Unconvincing and the Cost Is Prohibitive

Presenter: David J. Cohen

September 17, 2022

Presentation TCT 2022

Selective Use: Only in Vulnerable Patients

Presenter: John K. Forrest

September 17, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Daily News

Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection

L.A. McKeown

August 23, 2022

News Daily News

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Michael O'Riordan

March 11, 2020

News Daily News

Add-on Payment Now in Effect for Sentinel Protection Device During TAVR

Todd Neale

October 01, 2018

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Shelley Wood

July 20, 2018

Presentation TVT 2017

Device Design Features and Findings From EU Clinical Trials

Presenter: Joachim Schofer

June 15, 2017

Presentation TVT 2017

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Presenter: Axel Linke

June 15, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

Advertisement

Meta-analysis Quashes Hopes for Routine Embolic Protection in TAVI

TCTMD’s Top 10 Most Popular Stories for April 2025

TCTMD’s Top 10 Most Popular Stories for March 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

Top Structural Heart News of 2022

The Biggest News of 2022: TCTMD’s Top 10

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

None Use: The Data Are Unconvincing and the Cost Is Prohibitive

Selective Use: Only in Vulnerable Patients

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Add-on Payment Now in Effect for Sentinel Protection Device During TAVR

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Device Design Features and Findings From EU Clinical Trials

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content